{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-085864","form_type":"8-K","ticker":"CLSDQ","cik":"0001539029","company_name":"Clearside Biomedical, Inc.","filed_at":"2024-07-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.450989+00:00","generated_at":"2026-05-31T16:53:36.510408+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"low","headline":"Clearside Biomedical holds KOL webinar on suprachoroidal delivery; no new financial data","bullets":["Company hosted virtual Suprachoroidal Delivery KOL Webinar on July 24, 2024.","Attached slide presentation (Exhibit 99.1) contains only a title slide with no substantive data.","No material financial or business updates were disclosed in the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-085864","json":"https://secwatch.observer/filing/0000950170-24-085864.json","markdown":"https://secwatch.observer/filing/0000950170-24-085864.md","text":"https://secwatch.observer/filing/0000950170-24-085864.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1539029/000095017024085864/0000950170-24-085864-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1539029/000095017024085864/clsd-20240724.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T16:53:36.510408+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}